TegoSens is developing a universally adoptable, non-invasive, and portable device that provides early actionable detection of direct lung tissue specific fluid levels in patients, driving guideline-based therapies for specific conditions such as heart failure. The TegoSens solution is extremely competitive, yet complementary to existing diagnostic offerings and addresses a significant unmet need for the management of patients at point of care and home.

In the News

TegoSens in the News

Ikove and its portfolio of companies are making noise with groundbreaking innovation.

December 9, 2021
Subscribe for our News & Insights
Join our newsletter to stay up to date on features and releases.
By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ikove makes no warranties, express or implied, regarding any of the information on this website. None of the information on this website is investment advice. This website is not a solicitation of investment or offer to purchase or sell securities.